‘In China For Global’ Approach Fuels Chinese Biotech Forays

China's emerging role as a launch pad for global biotech ventures is slowly taking shape, fueled by ready venture capital funding and strong government support. Although capital outflow controls are tightening, the number of biotech deals will ratchet up, executives say.

Yuyang garden

A new crop of biotech startups in China is looking to partner with global players to develop antibodies to treat life-threatening conditions like cancer. The so-called "in China for Global" model is a drastic departure from "in China for China" strategy that has been trotted out as an ideal path for years.

Despite still lacking a comprehensive ecosystem for innovation, China is already on the cusp of a breakthrough, some say. Liang...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia